+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Microfluidics Market Size, Share & Trends Analysis Report by Application (Medical/Healthcare, Non-Medical), Material (Silicon, Glass), Technology, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 200 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4827917
The global microfluidics market size is expected to reach USD 71.90 billion by 2030, registering CAGR of 12.22% from 2024 to 2030, according to the report. The demand for microfluidics-based devices is expected to increase due to the introduction of improved technology such as digital microfluidics, which enables on-chip biochemical analysis. An increase in research activities undertaken by analytical and clinical researchers have also driven the demand for microfluidics device. For instance, in May 2022, a research team from the University of Minnesota developed an innovative microfluidic chip for disease diagnosing that uses a minimum number of components and can be operated wirelessly by a smartphone.

Miniature microfluidic-based tools are gaining significant popularity among consumers, which has encouraged companies to invest in their development. Since microfluidics is the underlying principle of lab-on-a-chip devices, it offers various benefits such as minimal sample volume, minimal reagent usage, reduced waste, and rapid processing. Fully automated microfluidics with enhanced functional capabilities, and robust modularity are creating growth opportunities for manufacturers operating in the market. This can be attributed to the fact that modular chips can interface with several instruments. In addition, companies operating in the field of drug discovery are striving to minimize overhead costs and timelines to offset the estimated decline in revenue owing to a significant number of drugs going off-patent.

The implementation of microfluidics is expanding in the field of diagnostics, especially in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. The combination of microfluidic components with POC devices is largely focused on achieving sensitivity, stability, accuracy, affordability, and obtaining minimally invasive POC technology. Microfluidic POC technologies are expected to enhance patient care by ensuring personalization, early disease detection, and easy monitoring.

In addition, COVID-19 has further upscaled the use of microfluidics. Point-of-care testing involves small equipment, regulates the process, and has limited testing cycles. This allows single or multiple research laboratory services to evaluate biological samples and diagnose harmful diseases simultaneously. In general, stage assessment and rapid detection of viral epidemics are vital to overcoming pandemic situations and diagnosing rapidly. Therefore, combining microfluidic devices with point-of-care testing enhances detection efficiency. At the same time, point-of-care testing of microfluidic chips enhances user accessibility, improves sensitivity and accuracy, and reduces the detection time, all of which are advantageous in detecting SARS-CoV-2.

Further, several acquisitions in the microfluidics industry are aimed at enhancing technologies for expanding the scope of microfluidics-related applications. In June 2021, Danaher Corporation announced that Precision NanoSystems (PNI), a Canada-based solution provider, was acquired by its life science business. PNI offered proprietary genetic toolkit platforms, including LNP delivery and nanoparticle manufacturing via the microfluidic-based platform, which further complemented the company’s portfolio of life science products.

On the other hand, high operational costs hinder the microfluidics market growth to a certain extent. The fabrication of microfluidics chips has certain issues such as open channel construction that require bonding of machine parts to form a final enclosed structure. The open channel is formed by the etching of glass or silicon. This step is slow, costly, and requires the use of aggressive chemicals. In addition, most of the microfluidic prototyping methods are not compatible with the batch process, and are also complicated and costly.

Microfluidics Market Report Highlights

  • Based on application, the medical segment held the highest revenue share of the market in 2023 and is expected to exhibit a CAGR of 12.56% from 2024-2030.
  • Based on material, the polydimethylsiloxane (PDMS) segment held the highest market share in 2023 and is expected to grow at a CAGR of 13.59% from 2024-2030.
  • Based on technology, the lab-on-a-chip segment dominated the market in 2023 and is expected to reveal a CAGR of 11.06% during the forecast period.
  • North America dominated the market with a revenue share of 42.69% in 2023 and is projected to exhibit a CAGR of 10.57% during the forecast period.


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Application & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Application & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for low-volume sample analysis
3.2.1.2. Growing penetration of microfluidics in diagnostics market
3.2.1.3. Introduction of advanced technologies
3.2.2. Market Restraint Analysis
3.2.2.1. High operational cost
3.2.2.2. Interfacing and integration
3.2.2.3. Complex fabrication process
3.2.3. Market Opportunity Analysis
3.2.3.1. Investments by companies in technological advancements
3.2.3.2. Growing adoption of point-of-care (POC) tests
3.2.3.3. Expansion of application scope for microfluidics technology
3.3. Industry Analysis Tools
3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.3.2. Porter's Five Forces Analysis
3.4. COVID-19 Impact Analysis
Chapter 4. Microfluidics Market: Application Business Analysis
4.1. Microfluidics Market: Application Movement Analysis
4.2. Medical
4.2.1. PCR & RT-PCR
4.2.1.1. Global PCR & RT-PCR Market, 2018 - 2030 (USD Million)
4.2.2. Gel electrophoresis
4.2.2.1. Global Gel electrophoresis Market, 2018 - 2030 (USD Million)
4.2.3. Microarrays
4.2.3.1. Global Microarrays Market, 2018 - 2030 (USD Million)
4.2.4. ELISA
4.2.4.1. Global ELISA Market, 2018 - 2030 (USD Million)
4.2.5. Others
4.2.5.1. Global Others Market, 2018 - 2030 (USD Million)
4.3. Non-Medical
4.3.1. Global Non-Medical Market, 2018 - 2030 (USD Million)
Chapter 5. Microfluidics Market: Material Business Analysis
5.1. Microfluidics Market: Material Movement Analysis
5.2. Silicon
5.2.1. Global Silicon Market, 2018 - 2030 (USD Million)
5.3. Glass
5.3.1. Global Glass Market, 2018 - 2030 (USD Million)
5.4. Polymer
5.4.1. Global Polymer Market, 2018 - 2030 (USD Million)
5.5. Polydimethylsiloxane (PDMS)
5.5.1. Global Polydimethylsiloxane (PDMS) Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 6. Microfluidics Market: Technology Business Analysis
6.1. Microfluidics Market: Technology Movement Analysis
6.2. Lab-on-a-chip
6.2.1. Global Lab-on-a-chip Market, 2018 - 2030 (USD Million)
6.2.2. Medical
6.2.2.1. Medical Market, 2018 - 2030 (USD Million)
6.2.3. Non-medical
6.2.3.1. Non-medical Market, 2018 - 2030 (USD Million)
6.3. Organs-on-chips
6.3.1. Global Organs-on-chips Market, 2018 - 2030 (USD Million)
6.3.2. Medical
6.3.2.1. Medical Market, 2018 - 2030 (USD Million)
6.3.3. Non-medical
6.3.3.1. Non-medical Market, 2018 - 2030 (USD Million)
6.4. Continuous flow microfluidics
6.4.1. Global Continuous Flow Microfluidics Market, 2018 - 2030 (USD Million)
6.4.2. Medical
6.4.2.1. Medical Market, 2018 - 2030 (USD Million)
6.4.3. Non-medical
6.4.3.1. Non-medical Market, 2018 - 2030 (USD Million)
6.5. Optofluidics and microfluidics
6.5.1. Global Optofluidics and microfluidics Market, 2018 - 2030 (USD Million)
6.5.2. Medical
6.5.2.1. Medical Market, 2018 - 2030 (USD Million)
6.5.3. Non-medical
6.5.3.1. Non-medical Market, 2018 - 2030 (USD Million)
6.6. Acoustofluidics and microfluidics
6.6.1. Global Acoustofluidics and microfluidics Market, 2018 - 2030 (USD Million)
6.6.2. Medical
6.6.2.1. Medical Market, 2018 - 2030 (USD Million)
6.6.3. Non-medical
6.6.3.1. Non-medical Market, 2018 - 2030 (USD Million)
6.7. Electrophoresis and microfluidics
6.7.1. Global Electrophoresis and microfluidics Market, 2018 - 2030 (USD Million)
6.7.2. Medical
6.7.2.1. Medical Market, 2018 - 2030 (USD Million)
6.7.3. Non-medical
6.7.3.1. Non-medical Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Microfluidics Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Microfluidics Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target disease prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. U.S. Microfluidics Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target disease prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Canada Microfluidics Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Microfluidics Market, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target disease prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. UK Microfluidics Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target disease prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Germany Microfluidics Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target disease prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. France Microfluidics Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target disease prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Italy Microfluidics Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target disease prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Spain Microfluidics Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target disease prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Denmark Microfluidics Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target disease prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Sweden Microfluidics Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target disease prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Norway Microfluidics Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Microfluidics Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target disease prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Japan Microfluidics Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target disease prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. China Microfluidics Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target disease prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. India Microfluidics Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target disease prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Australia Microfluidics Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target disease prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Thailand Microfluidics Market, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target disease prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. South Korea Microfluidics Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Microfluidics Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target disease prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Brazil Microfluidics Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target disease prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Mexico Microfluidics Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target disease prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Argentina Microfluidics Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Microfluidics Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target disease prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. South Africa Microfluidics Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target disease prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Saudi Arabia Microfluidics Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target disease prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Microfluidics Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target disease prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Kuwait Microfluidics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. Illumina, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. F. Hoffmann-La Roche Ltd
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PerkinElmer, Inc
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Agilent Technologies, Inc
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Rad Laboratories, Inc
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Danaher Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Abbott
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Thermo Fisher Scientific Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Standard BioTools, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
List of Tables
Table 1 Some commercialized POCT devices based on NAT.
Table 2 List of FDA-approved microfluidic-based POC tests
Table 3 Research institutes in Canada working on microfabricated microfluidics
Table 4 Overview of magnetic, colorimetric, plasmonic, electrochemical, and lateral flow assays
Table 5 Several approaches for microfluidic PCR devices including commercial PCR devices
Table 6 Major types of micro mosaic immunoassays
Table 7 Particle-focusing techniques applied in microfluidic flow cytometry
Table 8 Comparison of detection of food allergens by commercial ELISA kits and the microfluidic ELISA biosensor
Table 9 Materials and their respective technologies for micro structuring
Table 10 Comparison of polymers with glass
Table 11 Distinctive features of continuous-flow microfluidics and their usage in materials synthesis
Table 12 Different applications of acoustofluidic separation
Table 13 List of established companies
Table 14 List of emerging companies (contd.)
Table 15 List of Secondary Sources
Table 16 List of Abbreviations
Table 17 Global Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 18 Global Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 19 Global Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 20 Global Microfluidics Market, by Region, 2018 - 2030 (USD Million)
Table 21 North America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 22 North America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 23 North America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 24 U.S. Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 25 U.S. Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 26 U.S. Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 27 Canada Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 28 Canada Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 29 Canada Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 30 Europe Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 31 Europe Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 32 Europe Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 33 Europe Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 34 Germany Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 35 Germany Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 36 Germany Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 37 UK Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 38 UK Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 39 UK Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 40 Norway Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 41 Norway Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 42 Norway Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 43 Sweden Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 44 Sweden Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 45 Sweden Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 46 Denmark Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 47 Denmark Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 48 Denmark Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 49 France Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 50 France Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 51 France Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 52 Italy Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Italy Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 54 Italy Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 59 China Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 60 China Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 61 China Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 62 Japan Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 63 Japan Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 64 Japan Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 65 India Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 66 India Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 67 India Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 68 Australia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 69 Australia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 70 Australia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 71 Thailand Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 72 Thailand Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 73 Thailand Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 74 Latin America Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 75 Latin America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 76 Latin America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 77 Latin America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 78 Brazil Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 79 Brazil Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 80 Brazil Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 81 Mexico Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Mexico Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 83 Mexico Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 84 Argentina Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 85 Argentina Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 86 Argentina Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 88 Middle East & Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 89 Middle East & Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 90 Middle East & Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 91 South Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 92 South Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 93 South Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 97 UAE Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 98 UAE Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 99 UAE Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 100 Kuwait Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 101 Kuwait Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 102 Kuwait Microfluidics Market, by Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Microfluidics market estimation process
Fig. 8 Market snapshot
Fig. 9 Market trends & outlook
Fig. 10 Microfluidics market segmentation
Fig. 11 Penetration and growth prospect mapping
Fig. 12 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market driver impact
Fig. 15 Market restraint impact
Fig. 16 Emerging applications of automated and miniaturized microfluidics
Fig. 17 Companies developing automated and miniaturized microfluidics
Fig. 18 Extending applications of microfluidics technology
Fig. 19 Photolithographic procedure
Fig. 20 Types of COVID-19 tests
Fig. 21 Advantages of lab-on-chip devices for COVID-19 testing
Fig. 22 Microfluidics market: technology outlook and key takeaways
Fig. 23 Microfluidics market: technology movement analysis
Fig. 24 Microfluidics market estimates and forecast for medical technologies, 2018 - 2030 (USD Million)
Fig. 25 Microfluidics market estimates and forecast for PCR & RT-PCR, 2018 - 2030 (USD Million)
Fig. 26 Microfluidics market estimates and forecast for gel electrophoresis, 2018 - 2030 (USD Million)
Fig. 27 Microfluidics market estimates and forecast for microarrays, 2018 - 2030 (USD Million)
Fig. 28 Microfluidics market estimates and forecast for ELISA, 2018 - 2030 (USD Million)
Fig. 29 Different detection methods for microfluidic flow cytometry
Fig. 30 Microfluidics market estimates and forecast for other technologies, 2018 - 2030 (USD Million)
Fig. 31 Microfluidics market estimates and forecast for non-medical technologies, 2018 - 2030 (USD Million)
Fig. 32 Microfluidics market: material outlook and key takeaways
Fig. 33 Microfluidics market: material movement analysis
Fig. 34 Pros and cons of silicon
Fig. 35 Microfluidics market estimates and forecast for silicon, 2018 - 2030 (USD Million)
Fig. 36 Advantages of glass as microfluidic material
Fig. 37 Microfluidics market estimates and forecast for glass, 2018 - 2030 (USD Million)
Fig. 38 Types of polymers used to develop microfluidic devices
Fig. 39 Microfluidics market estimates and forecast for polymer, 2018 - 2030 (USD Million)
Fig. 40 Microfluidics market estimates and forecast for PDMS, 2018 - 2030 (USD Million)
Fig. 41 Microfluidics market estimates and forecast for other materials, 2018 - 2030 (USD Million)
Fig. 42 Microfluidics market: application outlook and key takeaways
Fig. 43 Microfluidics market: Application movement analysis
Fig. 44 Microfluidics market estimates and forecast for lab-on-a-chip, 2018 - 2030 (USD Million)
Fig. 45 Medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Non-medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Microfluidics market estimates and forecast for organs-on-chip, 2018 - 2030 (USD Million)
Fig. 48 Medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Non-medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Microfluidics market estimates and forecast for continuous flow microfluidics, 2018 - 2030 (USD Million)
Fig. 51 Medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Non-medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Microfluidics market estimates and forecast for optofluidics and microfluidics, 2018 - 2030 (USD Million)
Fig. 54 Medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Non-medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Microfluidics market estimates and forecast for acoustofluidics and microfluidics, 2018 - 2030 (USD Million)
Fig. 57 Medical applications of acoustofluidics
Fig. 58 Medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Non-medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Microfluidics market estimates and forecast for electrophoresis and microfluidics, 2018 - 2030 (USD Million)
Fig. 61 Medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Non-medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Regional marketplace: regional outlook and key takeaways
Fig. 64 Microfluidics regional outlook, 2021 & 2030
Fig. 65 North America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 U.S. microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Canada microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Europe microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Germany microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 UK microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 France microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Italy microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73Denmark microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Norway microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Sweden microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Asia Pacific microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Japan microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 China microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 India microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Australia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Thailand microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Latin America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Brazil microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Mexico microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Argentina microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 MEA microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 South Africa microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 UAE microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Kuwait microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Strategy framework
Fig. 92 Participant categorization

Companies Profiled

  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer, Inc
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Standard BioTools, Inc.

Methodology

Loading
LOADING...